Tag: Dravet Syndrome
FDA Approves Epidiolex to Treat Tuberous Sclerosis Seizures
CARLSBAD, Calif. – Greenwich Biosciences, Inc. and its parent company GW Pharmaceuticals, a British company involved in the development and manufacturing of plant-derived cannabinoid...
Pioneering CBD Patient Charlotte Figi Has Died; COVID-19 Suspected
DENVER – Charlotte Figi has died at 13, presumably due to complications related to COVID-19. The Colorado girl kick-started the worldwide CBD movement when...
Epidiolex Becomes First FDA Approved Cannabis-based Drug
LONDON – UK-based pharmaceutical company GW Pharmaceuticals on Monday announced that cannabis-based drug Epidiolex has received approval from the U.S. Food and Drug Administration....
FDA Panel Recommends Approval for Cannabis-Derived Medication
WASHINGTON D.C. – An FDA advisory committee last Thursday gave an unanimous recommendation for cannabis-derived drug Epidiolex to be approved for use by the...
First FDA Approved Cannabis Medication May Not be Available in Colorado
UPDATE: A representative from GW Pharmaceuticals clarified that Epidiolex is formulated to specifically treat Lennox Gastaut syndrome and Dravet syndrome. Scheduled date for pending...
Study shows Benefits of CBD on Rare Form of Epilepsy
The New England Journal of Medicine this week published study results, which show cannabidiol, aka CBD, is effective at lessening or eliminates seizures in...
